ALZI.V Alzai Health Corp.

Healthcare Biotechnology TSX Venture Exchange
0.1600 CAD
Close of Nov 7, 2026
0.1600 0.5000
Market cap
CAD 10.4M
P/E
-
P/B
7.23x
ROE
-261.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.

Is ALZI.V undervalued?

Graham number

The Graham number of Alzai Health Corp. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Alzai Health Corp. fundamental analysis

No fundamental analysis for Alzai Health Corp. yet.

Alzai Health Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Alzai Health Corp.

Alzai Health Corp., a healthcare technology company, provides artificial intelligence driven solution for risk screening. The company offers risk screening solutions for Mild Alzheimer's Disease and Mild Cognitive Impairment. It caters to various markets including healthcare providers and payors, pharmaceutical companies, research organizations, and research sites, clinical trials and research companies, and public health and private payors. The company was incorporated in 2…

Full company profile